603882 金域医学
已收盘 07-03 15:00:00
资讯
新帖
简况
金域医学（603882）披露回购股份进展公告，7月1日股价上涨5.2%
证券之星 · 07-01 23:03
金域医学（603882）披露回购股份进展公告，7月1日股价上涨5.2%
股市必读：金域医学（603882）6月26日收盘跌6.73%，主力净流出1081.29万元
证券之星 · 06-29
股市必读：金域医学（603882）6月26日收盘跌6.73%，主力净流出1081.29万元
每周股票复盘：金域医学（603882）2025年净亏损1.73亿
证券之星 · 06-28
每周股票复盘：金域医学（603882）2025年净亏损1.73亿
金域医学（603882）披露控股子公司认购私募基金份额公告，6月25日股价下跌0.96%
证券之星 · 06-25
金域医学（603882）披露控股子公司认购私募基金份额公告，6月25日股价下跌0.96%
金域医学（603882）披露2025年年度股东会会议资料，6月22日股价上涨0.12%
证券之星 · 06-22
金域医学（603882）披露2025年年度股东会会议资料，6月22日股价上涨0.12%
金域医学（603882）披露与关联人共同投资暨关联交易进展公告，6月18日股价上涨0.37%
证券之星 · 06-18
金域医学（603882）披露与关联人共同投资暨关联交易进展公告，6月18日股价上涨0.37%
金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务
智通财经 · 06-12
金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务
每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元
证券之星 · 06-07
每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元
金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权
证券之星 · 06-06
金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权
金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%
证券之星 · 06-02
金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%
每周股票复盘：金域医学（603882）回购股份比例达1.01%
证券之星 · 05-31
每周股票复盘：金域医学（603882）回购股份比例达1.01%
金域医学新注册《检测方法精密度评估系统V1.0.5》项目的软件著作权
证券之星 · 05-30
金域医学新注册《检测方法精密度评估系统V1.0.5》项目的软件著作权
金域医学（603882）披露以集中竞价交易方式回购公司股份比例达1%暨回购进展公告，5月28日股价下跌0.34%
证券之星 · 05-28
金域医学（603882）披露以集中竞价交易方式回购公司股份比例达1%暨回购进展公告，5月28日股价下跌0.34%
金域医学新注册《KMLink双向对接平台-客户端系统V1.1.1.0》等4个项目的软件著作权
证券之星 · 05-28
金域医学新注册《KMLink双向对接平台-客户端系统V1.1.1.0》等4个项目的软件著作权
每周股票复盘：金域医学（603882）已回购217.51万股
证券之星 · 05-10
每周股票复盘：金域医学（603882）已回购217.51万股
金域医学新注册《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权
证券之星 · 05-09
金域医学新注册《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权
金域医学（603882）披露关于新增回购专用证券账户的公告，5月6日股价上涨0.7%
证券之星 · 05-06
金域医学（603882）披露关于新增回购专用证券账户的公告，5月6日股价上涨0.7%
金域医学（603882）披露调整2026年回购股份方案资金来源公告，4月29日股价上涨0.77%
证券之星 · 04-29
金域医学（603882）披露调整2026年回购股份方案资金来源公告，4月29日股价上涨0.77%
金域医学（603882）2026年一季报简析：净利润同比增长254%，盈利能力上升
证券之星 · 04-26
金域医学（603882）2026年一季报简析：净利润同比增长254%，盈利能力上升
每周股票复盘：金域医学（603882）2026年Q1净利增254%
证券之星 · 04-26
每周股票复盘：金域医学（603882）2026年Q1净利增254%
加载更多
公司概况
公司名称：
广州金域医学检验集团股份有限公司
所属行业：
卫生
上市日期：
2017-09-08
主营业务：
广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司参与获批国家科技重大专项4项，国家“战略性科技创新合作”重点专项1项。全年发表论文共101篇，其中SCI论文32篇，学术影响力持续提升。
发行价格：
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":23.86,"timestamp":1783062000000,"preClose":23.42,"halted":0,"volume":5002145,"delay":0,"changeRate":0.0188,"floatShares":459999999,"shares":463000000,"eps":-0.2217,"marketStatus":"已收盘","change":0.44,"latestTime":"07-03 15:00:00","open":23.6,"high":24.09,"low":23.5,"amount":119000000,"amplitude":0.0252,"askPrice":23.86,"askSize":28,"bidPrice":23.85,"bidSize":18,"shortable":0,"etf":0,"ttmEps":-0.2217,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"adjPreClose":23.42,"symbolType":"stock","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":25.76,"lowLimit":21.08,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"isCdr":false,"pbRate":1.74,"roa":"--","roe":"0.65%","epsLYR":-0.37,"committee":-0.592664,"marketValue":11053000000,"turnoverRate":0.0109,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-07-06。","floatMarketCap":10979000000},"requestUrl":"/m/hq/s/603882","defaultTab":"news","newsList":[{"id":"2648527544","title":"金域医学（603882）披露回购股份进展公告，7月1日股价上涨5.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648527544","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648527544?lang=zh_cn&edition=full","pubTime":"2026-07-01 23:03","pubTimestamp":1782918196,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，金域医学报收于23.65元，较前一交易日上涨5.2%，最新总市值为109.56亿元。该股当日开盘22.86元，最高24.0元，最低22.31元，成交额达1.56亿元，换手率为1.46%。近日，广州金域医学检验集团股份有限公司发布《关于以集中竞价交易方式回购公司股份的进展公告》。截至2026年6月30日，已累计回购661.38万股，占总股本1.43%，支付金额17,342.37万元，回购价格区间为23.36元/股至28.79元/股。回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0042","603882","BK0284","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343960","title":"股市必读：金域医学（603882）6月26日收盘跌6.73%，主力净流出1081.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647343960?lang=zh_cn&edition=full","pubTime":"2026-06-29 03:11","pubTimestamp":1782673869,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，金域医学报收于22.16元，下跌6.73%，换手率1.68%，成交量7.72万手，成交额1.75亿元。交易信息汇总股价提醒6月26日金域医学收盘报22.16元，跌6.73%，当日成交1.75亿元。前10个交易日主力资金累计净流出3271.61万元，股价累计下跌6.73%；融资余额累计减少110.09万元，融券余量累计减少4700股。资金流向6月26日主力资金净流出1081.29万元，游资资金净流入717.26万元，散户资金净流入364.03万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","SG9999001069.SGD","603882","BK0236","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646132913","title":"每周股票复盘：金域医学（603882）2025年净亏损1.73亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2646132913","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646132913?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:41","pubTimestamp":1782585669,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，金域医学报收于22.16元，较上周的24.59元下跌9.88%。本周，金域医学6月23日盘中最高价报25.12元。公司公告汇总广州金域医学检验集团股份有限公司2025年年度股东会会议资料涵盖会议议程、董事会工作报告、利润分配预案、续聘审计机构、董事及高管薪酬管理制度、董事薪酬确认议案等内容。股本股东变化股东圣域钫持有广州金域医学检验集团股份有限公司股份21,000,000股，占总股本的4.53%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0042","603882","BK0284","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646099128","title":"金域医学（603882）披露控股子公司认购私募基金份额公告，6月25日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646099128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646099128?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:29","pubTimestamp":1782397754,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，金域医学报收于23.76元，较前一交易日下跌0.96%，最新总市值为110.07亿元。该股当日开盘23.88元，最高24.15元，最低22.88元，成交额达1.43亿元，换手率为1.33%。近日，广州金域医学检验集团股份有限公司发布《关于控股子公司认购私募基金份额的公告》。KINGWIK作为有限合伙人出资后预计占基金出资比例约4.70%。本次交易不构成关联交易，亦不构成重大资产重组，无需提交公司董事会或股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","603882","BK0284","BK0042","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645107308","title":"金域医学（603882）披露2025年年度股东会会议资料，6月22日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645107308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645107308?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:47","pubTimestamp":1782139637,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，金域医学报收于24.62元，较前一交易日上涨0.12%，最新总市值为114.05亿元。该股当日开盘24.75元，最高24.75元，最低23.56元，成交额达1.26亿元，换手率为1.14%。近日，广州金域医学检验集团股份有限公司披露《2025年年度股东会会议资料》。2025年公司实现营业收入60.30亿元，同比减少16.12%，归母净利润为-1.73亿元，同比减亏54.56%。董事会共召开6次会议，审议多项重大事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","603882","BK0236","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084216","title":"金域医学（603882）披露与关联人共同投资暨关联交易进展公告，6月18日股价上涨0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084216","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644084216?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:47","pubTimestamp":1781794035,"startTime":"0","endTime":"0","summary":"近日，广州金域医学检验集团股份有限公司发布《关于与关联人共同投资暨关联交易的进展公告》。公告显示，公司于2026年6月12日召开第四届董事会第十二次会议，审议通过与关联人共同投资设立广州金坤医智科技有限公司的议案；公司使用自有资金认缴出资1,000万元，持股20%。公司名称为广州金坤医智科技有限公司，法定代表人为谢江涛，成立日期为2026年6月17日，经营范围为软件和信息技术服务业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","BK0284","BK0042","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642295697","title":"金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295697","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642295697?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:15","pubTimestamp":1781270135,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金域医学(603882.SH)发布公告，公司拟使用自有资金与广州市圣域钫投资咨询合伙企业(有限合伙)等公司共同投资设立广州金坤医智科技有限公司(简称“金坤医智”，暂定名)，注册资本5000万元。其中，公司认缴出资1000万元，持股比例为20%。金坤医智核心业务将聚焦“智慧医疗”，基于对医疗全场景的深度洞察，整合自研AI产品与生态伙伴资源，为医院、药企、保险、IVD厂商等多元客户提供医疗数智化综合解决方案及端到端全流程数智化服务，金坤医智的业务定位与公司主营业务形成互补协同、差异发展，有助于拓展公司在智慧医疗领域的战略布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK0284","603882","BK0236","SG9999001069.SGD","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127107","title":"每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127107?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:46","pubTimestamp":1780771574,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，金域医学报收于24.02元，较上周的25.6元下跌6.17%。本周，金域医学6月1日盘中最高价报26.32元。本周关注点公司公告汇总：金域医学已累计回购465.87万股，占总股本1.01%，支付金额12,553.21万元。回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0042","603882","BK0236","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641314238","title":"金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2641314238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641314238?lang=zh_cn&edition=full","pubTime":"2026-06-06 02:25","pubTimestamp":1780683915,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学（603882）新注册了《智慧检测线性区间分析系统V1.5.7》项目的软件著作权。今年以来金域医学新注册软件著作权33个，较去年同期减少了37.74%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息221条，著作权信息194条；此外企业还拥有行政许可61个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060600000116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","603882","159180","BK0236","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914576","title":"金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914576","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640914576?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:05","pubTimestamp":1780394721,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，金域医学报收于25.74元，较前一交易日下跌1.27%，最新总市值为119.24亿元。该股当日开盘26.05元，最高26.25元，最低25.53元，成交额达1.2亿元，换手率为1.01%。广州金域医学检验集团股份有限公司于2026年6月2日发布《关于以集中竞价交易方式回购公司股份的进展公告》。回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200035702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","SG9999001069.SGD","BK0042","BK0236","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639760466","title":"每周股票复盘：金域医学（603882）回购股份比例达1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639760466","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639760466?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:13","pubTimestamp":1780168390,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，金域医学报收于25.6元，较上周的26.14元下跌2.07%。本周关注点公司公告汇总：金域医学已累计回购股份465.87万股，占总股本1.01%。截至2026年5月28日，已累计回购465.87万股，占公司总股本的1.01%，支付金额12,553.21万元，回购最高价为28.79元/股，最低价为25.33元/股。本次回购符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","SG9999001069.SGD","BK0042","BK0236","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639671727","title":"金域医学新注册《检测方法精密度评估系统V1.0.5》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2639671727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639671727?lang=zh_cn&edition=full","pubTime":"2026-05-30 02:00","pubTimestamp":1780077650,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学（603882）新注册了《检测方法精密度评估系统V1.0.5》项目的软件著作权。今年以来金域医学新注册软件著作权32个，较去年同期减少了39.62%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息221条，著作权信息193条；此外企业还拥有行政许可61个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053000000644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","159180","BK0042","603882","BK0284","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638691711","title":"金域医学（603882）披露以集中竞价交易方式回购公司股份比例达1%暨回购进展公告，5月28日股价下跌0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638691711","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638691711?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:33","pubTimestamp":1779978794,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，金域医学报收于26.18元，较前一交易日下跌0.34%，最新总市值为121.28亿元。该股当日开盘26.23元，最高26.27元，最低25.73元，成交额达1.32亿元，换手率为1.1%。近日，广州金域医学检验集团股份有限公司发布《关于以集中竞价交易方式回购公司股份比例达1%暨回购进展公告》。本次回购符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","SG9999001069.SGD","BK0042","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638295680","title":"金域医学新注册《KMLink双向对接平台-客户端系统V1.1.1.0》等4个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638295680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638295680?lang=zh_cn&edition=full","pubTime":"2026-05-28 02:06","pubTimestamp":1779905180,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了4个项目的软件著作权，包括《KMLink双向对接平台-客户端系统V1.1.1.0》、《基于NGS的HLA动态深度抽提工具软件V1.0》、《金域Kmlink-GZCancer系统V1.0》、《检测下限智能分析系统V1.0.0》等。今年以来金域医学新注册软件著作权31个，较去年同期减少了41.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800001398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","159180","BK0284","SG9999001069.SGD","603882","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411001","title":"每周股票复盘：金域医学（603882）已回购217.51万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411001","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411001?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:12","pubTimestamp":1778350335,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，金域医学报收于28.13元，较上周的27.3元上涨3.04%。本周，金域医学5月8日盘中最高价报28.88元。本周关注点公司公告汇总：金域医学已累计回购217.51万股，占总股本的0.4695%。截至2026年4月30日，公司已累计回购股份217.51万股，占总股本的0.4695%，实际回购价格区间为26.22元/股至28.79元/股，已支付金额5,977.00万元。本次回购符合相关规定和方案要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","SG9999001069.SGD","BK0042","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634466207","title":"金域医学新注册《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2634466207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634466207?lang=zh_cn&edition=full","pubTime":"2026-05-09 02:04","pubTimestamp":1778263460,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《医学实验室质量管理智慧评估系统V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权27个，较去年同期减少了49.06%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息221条，著作权信息192条；此外企业还拥有行政许可58个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050900000223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","SG9999001069.SGD","BK0236","BK0284","159180","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633640185","title":"金域医学（603882）披露关于新增回购专用证券账户的公告，5月6日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633640185","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633640185?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:49","pubTimestamp":1778060986,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，金域医学报收于27.49元，较前一交易日上涨0.7%，最新总市值为127.35亿元。该股当日开盘27.52元，最高27.95元，最低27.35元，成交额达1.8亿元，换手率为1.42%。近日，广州金域医学检验集团股份有限公司发布《关于新增回购专用证券账户的公告》。回购期限为董事会审议通过之日起6个月内。公司已收到中国工商银行广州粤秀支行出具的融资承诺函，同意提供不超过18,000万元贷款用于回购股份，并已完成回购专用证券账户开立。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600028193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","603882","BK0042","BK0236","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631268515","title":"金域医学（603882）披露调整2026年回购股份方案资金来源公告，4月29日股价上涨0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631268515","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631268515?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:48","pubTimestamp":1777463302,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，金域医学报收于27.52元，较前一交易日上涨0.77%，最新总市值为127.49亿元。该股当日开盘27.09元，最高27.77元，最低27.03元，成交额达1.35亿元，换手率为1.07%。广州金域医学检验集团股份有限公司于2026年4月29日发布公告，宣布将2026年回购股份方案的资金来源由“自有资金”调整为“自有资金和自筹资金”，回购总额仍为1.5亿元至2亿元，价格不超过35.00元/股，期限为董事会审议通过之日起6个月内。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","603882","SG9999001069.SGD","BK0236","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630975807","title":"金域医学（603882）2026年一季报简析：净利润同比增长254%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2630975807","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630975807?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:14","pubTimestamp":1777155290,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金域医学发布2026年一季报。截至本报告期末，公司营业总收入13.51亿元，同比下降7.88%，归母净利润4279.05万元，同比上升254.0%。本报告期金域医学盈利能力上升，毛利率同比增幅4.96%，净利率同比增幅249.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630802396","title":"每周股票复盘：金域医学（603882）2026年Q1净利增254%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802396","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630802396?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:41","pubTimestamp":1777149669,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，金域医学报收于28.28元，较上周的27.22元上涨3.89%。股本股东变化股东户数变动截至2026年3月31日，金域医学股东户数为4.31万户，较2025年12月31日增加3077户，增幅7.68%。广州金域医学检验集团股份有限公司2026年第一季度报告2026年第一季度公司实现营业收入1,350,977,738.08元，同比下降7.88%；利润总额61,072,831.86元，同比增长263.67%；归母净利润42,790,549.78元，同比增长254.00%；扣非净利润51,838,135.77元，同比增长233.95%；基本每股收益0.09元，同比增长250.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","BK0042","603882","BK0236"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783164529484,"stockEarnings":[{"period":"1week","weight":0.0767},{"period":"1month","weight":-0.0289},{"period":"3month","weight":-0.0834},{"period":"6month","weight":-0.135},{"period":"1year","weight":-0.1286},{"period":"ytd","weight":-0.135}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0421},{"period":"6month","weight":0.0188},{"period":"1year","weight":0.1683},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"43126人(较上一季度增加7.68%)","perCapita":"10669股","listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","registeredCapital":"46325万元","survey":" 广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司参与获批国家科技重大专项4项，国家“战略性科技创新合作”重点专项1项。全年发表论文共101篇，其中SCI论文32篇，学术影响力持续提升。","listedPrice":6.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}